Sotera Health Company
NasdaqGS:SHC
Sector
Location
Market Cap
USD 3.38 B
Share Price
USD 11.91
Avg Daily Volume
1,181,662
Change (1 day)
-1.85%
Change (1 year)
-12.32%
Change (YTD)
-12.90%
Sotera Health Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 239.22 M
Sotera Health Company Operating Cash Flow is USD 239.22 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -238.12% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sotera Health Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -173.19 M, a -166.14% change year over year.
-
Sotera Health Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 261.87 M, a -4.90% change year over year.
-
Sotera Health Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 275.35 M, a 60.97% change year over year.
-
Sotera Health Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 171.05 M, a 47.82% change year over year.
StockViz
Competitors
Qiagen N.V.
USD 50.57
QGEN
-0.50
-0.98%
Maravai LifeSciences Holdings, Inc.
USD 2.41
MRVI
-0.07
-2.82%
Privia Health Group, Inc.
USD 19.59
PRVA
+0.11
0.56%
Certara, Inc.
USD 10.23
CERT
-0.41
-3.85%
Aclaris Therapeutics, Inc.
USD 1.53
ACRS
-0.02
-1.29%
Neogen Corporation
USD 4.70
NEOG
-0.13
-2.79%
Alignment Healthcare, Inc.
USD 13.00
ALHC
+1.22
10.36%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Qiagen N.V.
USD 50.57
QGEN
-0.50
-0.98%
Maravai LifeSciences Holdings, Inc.
USD 2.41
MRVI
-0.07
-2.82%
Privia Health Group, Inc.
USD 19.59
PRVA
+0.11
0.56%
Certara, Inc.
USD 10.23
CERT
-0.41
-3.85%
Aclaris Therapeutics, Inc.
USD 1.53
ACRS
-0.02
-1.29%
Neogen Corporation
USD 4.70
NEOG
-0.13
-2.79%
Alignment Healthcare, Inc.
USD 13.00
ALHC
+1.22
10.36%